Richardcyoung.com

The Online Home of Author and Investor, Dick Young

  • Home
  • How We Are Different
  • About Us
    • Foundation Principles
    • Contributors
  • Investing
    • You’ve Read The Last Issue of Intelligence Report, Now What?
  • Your Survival Guy
  • The Great Reset
  • COVID-19
  • My Rifles
  • Dividends and Compounding
  • Your Security
  • The Swiss Way
  • Dick Young
  • Debbie Young
  • Key West
  • Paris
  • Dick’s R&B Top 100
  • Liberty & Freedom Map
  • Bank Credit & Money
  • Your Survival Guy’s Super States
  • NNT & Cholesterol
  • Work to Make Money/Invest to Save Money
  • Your Health
  • Ron Paul
  • US Treasury Yield Curve: My Favorite Investor Tool

Johnson & Johnson Spinning Up Single-Dose COVID Vaccine

February 25, 2021 By The Editors

By joel bubble ben @ Shutterstock.com

The Miami Herald reports on Johnson & Johnson’s single-dose COVID-19 vaccine, writing:

The U.S. Food and Drug Administration released a report on Wednesday that says the one-dose Johnson & Johnson COVID-19 vaccine has a “favorable safety profile with no specific safety concerns,” clearing the way for emergency use authorization.

A committee of scientific experts will meet on Friday to discuss the vaccine’s safety and efficacy, as it did for the authorized Pfizer-BioNTech and Moderna shots. If the group decides to recommend the Johnson & Johnson vaccine for FDA authorization, the shot will become the nation’s third COVID-19 vaccine, joining the fight against the pandemic spurred by more contagious variants.

The vaccine requires one dose and can be stored for three months at normal temperatures, easing distribution efforts and accelerating vaccination rates compared to the two-dose Pfizer and Moderna shots that require ultra cold refrigeration, which some regions lack access to.

Dr. Paul Stoffels, chief scientific officer for Johnson & Johnson, said in January that the results “represent a promising moment.”

“The potential to significantly reduce the burden of severe disease, by providing an effective and well-tolerated vaccine with just one immunization, is a critical component of the global public health response.”

The Phase 3 clinical trial, which included nearly 44,000 participants 18 years and older, found that the Johnson & Johnson vaccine was overall 66% effective at preventing moderate to severe COVID-19 in the lab at least 28 days after getting jabbed.

If you’re willing to fight for Main Street America, click here to sign up for the Richardcyoung.com free weekly email.

Related Posts

  • Good Vaccine News from Johnson & Johnson
  • England’s PM Boris Johnson Showing COVID-19 Leadership
  • Understanding the COVID-19 Vaccine
  • Covid-19’s Hidden Hobbies
  • Author
  • Recent Posts
The Editors
Latest posts by The Editors (see all)
  • Making America Great Again Is What America Wants - March 20, 2023
  • Is Plant-Based Meat Unhealthy and Harmful to the Environment? - March 17, 2023
  • SPIES ON CAMPUS: The Chinese Have Invaded the Quad - March 16, 2023

Dick Young’s Must Reads

  • Hungarian Hardliner Viktor Orban Shows European Globalists the Way
  • DIGITAL ID: You Are More than a Soulless Digital Identity
  • BEYOND RUSSIA: America Strengthens India Ties to Counter China
  • TOP HEAVY: Focus on Big Indexing Could Cause Market Chaos
  • The Butterfly Effect and Chaotic Markets
  • U.S. Survival AR-7
  • The County Sheriff: America’s Last Hope
  • Making America Great Again Is What America Wants
  • FARM AMERICA: New York City’s Finest Cheesemongers
  • Being Fully American Means Americans First

Our Most Popular Posts

  • Pushing Back at ESG
  • Your Survival Guy’s BEST Insider’s Guide to Key West
  • Cheap Reliable Heating – a Life Saver
  • Are You Fairly Wealthy? I’m Listening
  • Biden Has Lost Control of the Northern Border Too
  • Who'd be Nuts Enough to Have Put Money into SVB?
  • Get Well Soon Taki
  • For Whom Is Your Portfolio Serving?
  • SPIES ON CAMPUS: The Chinese Have Invaded the Quad
  • Washington Is the Systemic Risk

Disclosure

RSS Youngresearch.com

  • Are You Fairly Wealthy? I’m Listening
  • Treasury Studying How to Increase Deposit Insurance
  • Your Survival Guy’s BEST Insider’s Guide to Key West
  • For Whom Is Your Portfolio Serving?
  • Who’s to Blame for Banking Vulnerability?
  • Mortgage Market Not Expected to Settle Down Soon
  • Are You Living Your Best Life?
  • Were Silicon Valley Bank’s Motivations for Taking Losses Pure?
  • Will the Black Swan Usher in Digital Dollars?
  • Major Rail Merger Gets Approval

RSS Yoursurvivalguy.com

  • Are You Fairly Wealthy? I’m Listening
  • How Long Is Your Water Supply Chain?
  • Your Survival Guy’s BEST Insider’s Guide to Key West
  • Be Wary of Those Who Wrap Themselves in Capes
  • For Whom Is Your Portfolio Serving?
  • ESG: Are Markets Ready for “A Needed Dose of Reality?”
  • Was Silicon Valley Bank a Victim of ESG?
  • Are You Living Your Best Life?
  • March RAGE Gauge: Will the Black Swan Usher in Digital Dollars?
  • Gretchen Whitmer Reviving Forced Unionization in Michigan

Who’d be Nuts Enough to Have Put Money into SVB?

Are You Fairly Wealthy? I’m Listening

Get Well Soon Taki

A Cashless Society Is A Debacle for Americans

How about Hiring Erik Prince to Crush the Drug Cartels?

Key West’s Best Burger

Copyright © 2023 | Terms & Conditions | About Us | Dick Young | Archives